EUVIMEDEUVIMED entdecken
Crossref

Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients

Mattia Donadoni, Maria Calloni, Maria Eva Romano, Alessandra Mutti, Arianna Bartoli, Leyla La Cava, Rosita Celano, Francesco Urso, Valentina Popescu Janu, Antonella Foschi, Francesco Casella, Alba Taino und 4 weitere

The Journal of Vascular Access · 2025

DOI: 10.1177/11297298241252896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Mattia Donadoni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Iloprost, Alprostadil, Catheterization, Peripheral, Vasodilator Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long peripheral catheters (LPCs) role in Difficult IntraVenous Access (DIVA) patients admitted to the emergency department has already been studied, resulting in a rapid, safe, and cost-effective procedure. Although their use in outpatient settings is established, there is a lack of studies assessing their benefits. In particular, rheumatologic outpatients affected by scleroderma, especially those affected by digital ulcers, are often treated with intravenous infusions of prostaglandin I 2 (PGI 2 ) analog (IV-PGI 2 A). Objective and methods: From 1 October 2021 to 31 March 2024, we conducted a prospective study enrolling DIVA outpatients affected by systemic sclerosis or undifferentiated connective tissue disease who needed IV-PGI 2 A therapy at L. Sacco Hospital in Milan (Italy). Each treatment cycle consisted of four consecutive days of infusion of iloprost or alprostadil. The primary aim was to assess the efficacy and potential complications associated with LPCs for IV-PGI 2 A.

Results

Twenty-six patients were enrolled 23 were females (88.5%), and the median age was 72 years (IQR 56–78.7). In total, 97 LPCs were inserted, with a mean number of insertions per patient/year of 2.3. An increase in LPCs insertion during the 30 months of the enrollment period was observed. Eighteen patients required more than one LPC placement, and in 61% of them, the second venipuncture was executed at a different site. No procedural complications were registered (accidental puncture of the brachial artery, accidental median nerve puncture, bleeding) nor late complications (Catheter-Related Thrombosis, Catheter-Related Bloodstream Infections, Accidental Removal).

Conclusions

Our experience shows that LPCs could be valuable and safe for rheumatologic outpatients. The increased number of insertions and new and total patients enrolled each year defines the satisfaction of patients and health care professionals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IloprostAlprostadilCatheterization, PeripheralVasodilator AgentsAmbulatory CareScleroderma, SystemicCatheters, IndwellingVascular Access DevicesHumansFemaleMaleMiddle AgedAgedProspective StudiesTreatment OutcomeInfusions, IntravenousTime FactorsEquipment DesignItaly

Stichwörter der Autor:innen

Difficult IntraVenous Access (DIVA)Long peripheral catheters (LPCs)alprostadililoprostmini-midlineoutpatientprostaglandin I2 analog (PGI2A)systemic sclerosisundifferentiated connective tissue disease

Substanzen

IloprostAlprostadilVasodilator Agents

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy.
  • Department of Rheumatology, "Luigi Sacco" Hospital, Milan, Italy.
  • Department of Infectious Diseases, "Luigi Sacco" Hospital, Milan, Italy.

ORCID-Profile: Antonio Gidaro

Zitieren

APA

Donadoni, M., Calloni, M., Romano, M. E., Mutti, A., Bartoli, A., La Cava, L., Celano, R., Urso, F., Popescu Janu, V., Foschi, A., Casella, F., Taino, A., Cogliati, C., Zappa, P., Masseroli, M. M., & Gidaro, A. (2025). Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients. The Journal of Vascular Access. https://doi.org/10.1177/11297298241252896

Vancouver

Donadoni M, Calloni M, Romano ME, Mutti A, Bartoli A, La Cava L, et al. Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients. The Journal of Vascular Access. 2025. doi:10.1177/11297298241252896

BibTeX
@article{Donadoni2025,
  author = {Donadoni, Mattia and Calloni, Maria and Romano, Maria Eva and Mutti, Alessandra and Bartoli, Arianna and La Cava, Leyla and Celano, Rosita and Urso, Francesco and Popescu Janu, Valentina and Foschi, Antonella and Casella, Francesco and Taino, Alba and Cogliati, Chiara and Zappa, Paolo and Masseroli, Matteo Maria and Gidaro, Antonio},
  title = {Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients},
  journal = {The Journal of Vascular Access},
  year = {2025},
  doi = {10.1177/11297298241252896}
}
Kostenlos starten →